Clinical Trials on Low Risk Prostate Cancer
Total 5804 results
-
University of California, San FranciscoNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedMetastatic Prostate Cancer | Castration Resistant Prostatic CancerUnited States
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRecurrent Prostate Cancer | Metastatic Prostate CancerFinland, Norway, Estonia, Denmark
-
José Joaquín MiraRecruitingProstate Cancer | Prostate Cancer DiagnosisSpain
-
Gulhane Training and Research HospitalRecruitingProstate Cancer | Prostate Cancer StageTurkey
-
Shanghai Proton and Heavy Ion CenterRecruitingLocalized Prostate CancerChina
-
West China HospitalNot yet recruitingProstate Cancer Metastatic
-
Sun Yat-sen UniversityRecruitingProstate Cancer MetastaticChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; Apices Soluciones S.L.CompletedProstate Cancer MetastaticSpain
-
University of FloridaCompleted
-
University of HawaiiGenentech, Inc.; DendreonCompletedProstate Cancer MetastaticUnited States
-
National Cancer Institute, EgyptCompletedProstate Cancer MetastaticEgypt
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Lund University HospitalCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Institut Paoli-CalmettesUnknown
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Chang Gung Memorial HospitalCompletedLatent Cancer ProstateTaiwan
-
Ferring PharmaceuticalsCompleted
-
UMC UtrechtRadboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; The...CompletedProstate Cancer AdenocarcinomaNetherlands, Belgium
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Sharp HealthCareWithdrawnMetastatic Prostate CancerUnited States
-
Baylor College of MedicineCompletedLocalized Prostate CancerUnited States
-
DexTech Medical ABTerminatedProstate Cancer MetastaticSweden
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
Centre Jean PerrinCompletedMetastatic Prostate CancerFrance
-
University Hospital, RouenCompleted
-
University of Colorado, DenverCompletedProstate Cancer ScreeningUnited States
-
University of FloridaWithdrawnMetastatic Prostate Cancer
-
Georgetown UniversityU.S. Army Medical Research and Development CommandCompleted
-
Lahey ClinicTerminated
-
Thomas Jefferson UniversityRecruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Soft Tissue MetastasesUnited States
-
Alliance Foundation Trials, LLC.BayerRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate CancerUnited States
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Roswell Park Cancer InstituteActive Biotech ABCompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
Marmara UniversityRecruitingProstatic Neoplasms | Prostate Cancer | Prostate Adenocarcinoma | Prostate Disease | Prostate Cancer StageTurkey
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Hormone-Resistant Prostate CancerCanada
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeSuspendedProstate Cancer | Prostate NeoplasmUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Adenocarcinoma Without Neuroendocrine DifferentiationUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLCRecruitingCastration-resistant Prostate CancerUnited Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedStage IV Prostate CancerUnited States
-
Stanford UniversityWithdrawnProstate Cancer | Castrate Resistant Prostate Cancer
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer | Castration-resistant Prostate CancerChina